CoChat
Sign Up
Cited by 251Chronic Obstructive Pulmonary Disease (COPD) ResearchAntioxidant Activity and Oxidative StressRedox biology and oxidative stress

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms

Open access
McGuinness, Adam, Sapey, Elizabeth·2017·Journal of Clinical Medicine
DOI 10.3390/jcm6020021PMC PMC5332925
Open this paper in CoChat — free accountOpen PDF

Abstract

Markers of oxidative stress are increased in chronic obstructive pulmonary disease (COPD) and reactive oxygen species (ROS) are able to alter biological molecules, signaling pathways and antioxidant molecule function, many of which have been implicated in the pathogenesis of COPD. However, the involvement of ROS in the development and progression of COPD is not proven. Here, we discuss the sources of ROS, and the defences that have evolved to protect against their harmful effects. We address the role that ROS may have in the development and progression of COPD, as well as current therapeutic attempts at limiting the damage they cause. Evidence has indicated that the function of several key cells appears altered in COPD patients, and expression levels of important oxidant and antioxidant molecules may be abnormal. Therapeutic trials attempting to restore equilibrium to these molecules have not impacted upon all facets of disease and whilst the theory behind ROS influence in COPD appears sound, current models testing relevant pathways to tissue damage are limited. The heterogeneity seen in COPD patients presents a challenge to our understanding, and further research is essential to identify potential targets and stratified COPD patient populations where ROS therapies may be maximally efficacious.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jcm6020021

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Molecular production of reactive species. Initiated by an inflammatory stimulus, a cascade begins that results in a variety of oxidative agents. Red boxes represent pro-inflammatory enzymes, whilst blue boxes represent anti-inflammatory enzymes. Superoxide dismutase (SOD) may be classed as both as its substrate and product are both capable of causing harm. NOX2, nicotinamide adenine dinucleotide phosphate(NADPH)-oxidase; iNOS, inducible nitric oxide synthase; O2·−, superoxide anion; ·NO, nitric oxide; SOD, superoxide dismutase; H2O2, hydrogen peroxide; CAT, catalase; GPx, glutathione peroxidase; MPO, myeloperoxidase; HOCl, hypochlorous acid; RCS + RNS, reactive nitrogen species + reactive carbon species; ONOO¯, peroxynitrite.
Figure 1 Molecular production of reactive species. Initiated by an inflammatory stimulus, a cascade begins that results in a variety of oxidative agents. Red boxes represent pro-inflammatory enzymes, whilst blue boxes represent anti-inflammatory enzymes. Superoxide dismutase (SOD) may be classed as both as its substrate and product are both capable of causing harm. NOX2, nicotinamide adenine dinucleotide phosphate(NADPH)-oxidase; iNOS, inducible nitric oxide synthase; O2·−, superoxide anion; ·NO, nitric oxide; SOD, superoxide dismutase; H2O2, hydrogen peroxide; CAT, catalase; GPx, glutathione peroxidase; MPO, myeloperoxidase; HOCl, hypochlorous acid; RCS + RNS, reactive nitrogen species + reactive carbon species; ONOO¯, peroxynitrite.CC BY · PubMed Central
Figure 2 Process of tissue damage in chronic obstructive pulmonary disease (COPD). 1. Influx of pro-inflammatory particles into lung. 2. Particles bind PRRs on the surface of lung epithelial or tissue macrophages, instigating a signalling cascade culminating in the release of pro-inflammatory cytokines. 3. Cytokines encourage the recruitment, migration and activation of peripheral neutrophils and monocytes, the latter of which mature to alveolar macrophages once recruited. Activation of these cells results in the further cytokine release, proteases and ROS, in turn fueling further recruitment and activation. In health, anti-proteases and anti-oxidants are present in very high levels, preventing excess damage to surrounding tissues, and limiting a positive feedback loop. In COPD, these levels may be lacking, resulting in increased areas of obligate tissue damage. 4. If insufficiently inhibited, proteases will degrade extracellular matrix, leading to tissue destruction and pathologies seen in COPD. O2·¯, superoxide anion; ·NO, nitric oxide; SOD, superoxide dismutase; H2O2, hydrogen peroxide; CAT, catalase; GPx, glutathione peroxidase; MPO, myeloperoxidase; HOCl, hypochlorous acid; ONOO−, peroxynitrite; TNFα, tumour necrosis factor α; IL8, Interleukin 8; MCP-1, monocyte chemoattractant protein 1; LPS, lipopolysaccharide; PRR, pattern recognition receptor; GSH, glutathione; PR3, proteinase 3; NE, neutrophil elastase; MMP9, matrix metalloproteinase 9; α1AT, α1 antitrypsin; SLPI, secretory leukocyte protease inhibitor.
Figure 2 Process of tissue damage in chronic obstructive pulmonary disease (COPD). 1. Influx of pro-inflammatory particles into lung. 2. Particles bind PRRs on the surface of lung epithelial or tissue macrophages, instigating a signalling cascade culminating in the release of pro-inflammatory cytokines. 3. Cytokines encourage the recruitment, migration and activation of peripheral neutrophils and monocytes, the latter of which mature to alveolar macrophages once recruited. Activation of these cells results in the further cytokine release, proteases and ROS, in turn fueling further recruitment and activation. In health, anti-proteases and anti-oxidants are present in very high levels, preventing excess damage to surrounding tissues, and limiting a positive feedback loop. In COPD, these levels may be lacking, resulting in increased areas of obligate tissue damage. 4. If insufficiently inhibited, proteases will degrade extracellular matrix, leading to tissue destruction and pathologies seen in COPD. O2·¯, superoxide anion; ·NO, nitric oxide; SOD, superoxide dismutase; H2O2, hydrogen peroxide; CAT, catalase; GPx, glutathione peroxidase; MPO, myeloperoxidase; HOCl, hypochlorous acid; ONOO−, peroxynitrite; TNFα, tumour necrosis factor α; IL8, Interleukin 8; MCP-1, monocyte chemoattractant protein 1; LPS, lipopolysaccharide; PRR, pattern recognition receptor; GSH, glutathione; PR3, proteinase 3; NE, neutrophil elastase; MMP9, matrix metalloproteinase 9; α1AT, α1 antitrypsin; SLPI, secretory leukocyte protease inhibitor.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 129 references

Research works printed but not linked: 2

  1. Walton, G.M., Begg, M., Amour, A., Hessel, E.M., Usher, A.K.H., Pottle, M., Chadwick, C., Stockley, R., Stockley, J.A., and Sapey, E. (, 2015). Targeting phosphoinositide 3 kinase reduces damaging neutrophil functions without impairing bacterial phagocytosis in COPD. Proceedings of the American Thoracic Society International Conference, Denver, CO, USA.
  2. Belchamber, 2015, Elevated mitochondrial reactive oxygen species in COPD macrophages at exacerbation and with bacterial phagocytosis, Am. J. Respir. Crit. Care, 191, A6377

Cited by

Sorted by citations

See all 251

Related

Metadata

Authors
McGuinness, A., & Sapey, E.
Affiliations
University of Birmingham (GB)
Corresponding author
McGuinness, Adam
ORCID
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2017-02-15
Volume
6
Issue
2
Pages
21
ISSN
2077-0383 (ISSN-L)
DOI
10.3390/jcm6020021
PMC
PMC5332925
OpenAlex
W2588693869
Cited by
243
References
129
Citations by year
2026: 16 · 2025: 23 · 2024: 40 · 2023: 28 · 2022: 32 · 2021: 33 · 2020: 19 · 2019: 23 · 2018: 23 · 2017: 6
FWCI
3.58
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
Funders
  • Academy of Medical Sciences (AMS-SGCL5-Sapey)
  • Medical Research Council (MR/L008335/1)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
chronic obstructive pulmonary disease, oxidative stress, reactive oxygen species, antioxidant defense, oxidant-antioxidant imbalance, COPD pathogenesis, COPD progression, oxidative stress biomarkers, antioxidant therapy, COPD heterogeneity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review